Ticker archive · $MRK

$MRK Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $MRK — including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

?? Positive AI Sentiment (+6.8 / 10)
  • Q3 Sales reached $18.09B vs. $17.31B expected, driven by Keytruda ($8.60B vs. $8.38B)
  • Adjusted EPS of $2.49 significantly beat expectations of $2.07
  • FY adjusted gross margin guidance reiterated at approximately 81%
Observed market reaction after signal
4h +4.41% · Peak +5.91%
?? Positive AI Sentiment (+6.8 / 10)
  • Q3 Adj. EPS of $2.49 vs. $2.07 consensus; Q3 revenue of $18.09B vs. $17.31B expected.
  • Keytruda sales reached $8.60B (exp. $8.38B); Gardasil sales $2.00B (exp. $1.75B).
  • FY Adj. EPS guidance raised to $2.77–$2.82 (from $2.66–$2.76); FY sales midpoint lifted.
Observed market reaction after signal
4h +4.51% · Peak +5.91%